Neuroscientific Biopharmaceuticals Ltd News

Neuroscientific Biopharmaceuticals Secures US FDA Guidance for Glaucoma Medication

Neuroscientific Biopharmaceuticals (ASX:NSB) secured guidance from the US Food and Drug Administration following a pre-investigational new drug meeting for advanced glaucoma medication EmtinB, accordi

MT NewswiresJun 11 11:12

NeuroScientific Biopharmaceuticals Secures AU$2 Million R&D Tax Rebate for Fiscal Year 2023; Shares Rise 6%

Neuroscientific Biopharmaceuticals (ASX:NSB) secured a AU$2.2 million rebate from the Australian government research and development tax incentive scheme for the fiscal year ended June 30, 2023, accor

MT NewswiresMar 20 08:07

NeuroScientific Biopharmaceuticals Limited's (ASX:NSB) Stock Has Shown Weakness Lately But Financial Prospects Look Decent: Is The Market Wrong?

Yahoo FinanceFeb 29 08:17

NeuroScientific Biopharmaceuticals CEO to Step Down

NeuroScientific Biopharmaceuticals (ASX:NSB) said Stephen Carter will step down as chief executive, effective Dec. 31. The company will undertake a search process for a new CEO, according to a Friday

MT NewswiresDec 1, 2023 14:01